<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02030717</url>
  </required_header>
  <id_info>
    <org_study_id>Dnr 151:2010/81099</org_study_id>
    <secondary_id>2008-001491-77</secondary_id>
    <nct_id>NCT02030717</nct_id>
  </id_info>
  <brief_title>Randomized Study of Spinal Anesthesia Compared With Traditional Epidural Anesthesia Concerning Peroperative and Postoperative Pain After Open Nephrectomy in Patients With Renal Cell Carcinoma</brief_title>
  <acronym>ASA</acronym>
  <official_title>Randomized Study of Spinal Anesthesia Compared With Traditional Epidural Anesthesia Concerning Peroperative and Postoperative Pain After Open Nephrectomy in Patients With Renal Cell Carcinoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Umeå University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Umeå</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Umeå University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aim to study whether spinal anesthesia (using: bupivacain, morfin och klonidin) can
      be better than epidural anesthesia during and after open surgery for renal cell carcinoma.
      Per- and postoperative pain after spinal anesthesia with klonidin can be reduced and, thus,
      shorten the hospital stay and rehabilitation of the patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Actual">May 2015</completion_date>
  <primary_completion_date type="Actual">May 2015</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative mobilisation index</measure>
    <time_frame>within the first 30 days (plus or minus 5 days) after surgery</time_frame>
    <description>Using a number of variables an index of mobilisation has been created; eg pain (10 graded scale), malaise, intravenous substitution, eating in dining room, Walking outside ward room, passage of stool, carrying urinary bladder catheter, can mobilise out of bed without help</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>time of hospitalization</measure>
    <time_frame>within the first 15 days after surgery</time_frame>
    <description>time in hospital after surgery until discharge</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Need of rescue analgetics</measure>
    <time_frame>within the first 15 days after surgery</time_frame>
    <description>the total amount of analgetics used besides the spinal infusion or the epidural infusion used</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Pre- and Postoperative Analgesia</condition>
  <condition>Spinal Anesthesia</condition>
  <condition>Renal Cell Carcinoma</condition>
  <arm_group>
    <arm_group_label>Spinal anesthesia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The drugs used in the spinal injection are: 12 mg bupivacain, 160 ug morfin och klonidin( &lt; 60 years 75 ug, 60 - 85 years old 60 ug and older than 85 years 45 ug)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Epidural anesthesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Epidural anesthesia patients group gets an epidural catheter at level Th 8- 10 with per- and postoperative infusion with a routine mixture of: bupivacain 1 mg/ml, fentanyl 1 ug/ml, and adrenalin 1 ug/ml) until termination.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>klonidin</intervention_name>
    <description>spinal injection of 12 mg bupivacain,160 ug morfin och klonidin, according to age</description>
    <arm_group_label>Spinal anesthesia</arm_group_label>
    <other_name>Brand name: Duraclon - FDA Apl No (NDA) 020615.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>epidural anesthesia</intervention_name>
    <description>epidural anesthesia: patients get an continuous infusion of a solution with bupivacain 1 mg/ml, fentanyl 1 ug/ml and adrenalin 1 ug/ml</description>
    <arm_group_label>Epidural anesthesia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  all patients in ASA score I - III, planned to be treated with open radical nephrectomy
             or nephron-sparing surgery having renal cell carcinoma

        Exclusion Criteria:

          -  patients in ASA score IV-V,

          -  patients with advanced tumour thrombus in vena cava inferior,

          -  patients with high risk for bleeding

          -  patients with previous chronic pain symptoms

          -  patients having drug abuse

          -  patients having cognitive deficiencies or dementia disease

          -  patients with any contraindication of either spinal or epidural anesthesia

          -  patients younger than 18 years and pregnant woman

          -  patients having a weight less than 45 kg or weight over 120 kg
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Borje Ljungberg, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Umea University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Umea University Hospital</name>
      <address>
        <city>Umea</city>
        <zip>901 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 7, 2014</study_first_submitted>
  <study_first_submitted_qc>January 7, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 8, 2014</study_first_posted>
  <last_update_submitted>June 3, 2015</last_update_submitted>
  <last_update_submitted_qc>June 3, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 4, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Spinal anesthesia</keyword>
  <keyword>Epidural anesthesia</keyword>
  <keyword>Klonidin</keyword>
  <keyword>renal cell carcinoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Carcinoma, Renal Cell</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

